Bosentas (Bosentan) 62.5mg/125mg*30's | Generic Endothelin Receptor Antagonist | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

分享
Product description

Generic Information: Bosentas (India)

Bosentas is an Indian generic of bosentan, manufactured by Cipla Ltd., one of the world's leading generic pharmaceutical companies. It is supplied in 62.5 mg and 125 mg strengths, each in a 30-tablet pack, covering both the starting and maintenance doses of the standard bosentan regimen. As a generic dual endothelin receptor antagonist, Bosentas delivers the same active ingredient as the originator at a much lower, out-of-pocket-friendly price.

What Is Bosentas Used For?

Bosentas is used to treat pulmonary arterial hypertension (PAH), WHO functional class II to IV, improving exercise ability and reducing clinical worsening. It is an oral, twice-daily medicine that is practical for long-term home use, and it is prescribed after a specialist confirms the diagnosis of PAH. The medicine is suitable for patients with idiopathic PAH, PAH associated with connective tissue disease, or PAH associated with congenital heart disease.

How Does Bosentas (Bosentan) Work?

The bosentan in Bosentas is a dual endothelin receptor antagonist that blocks both the ETA and ETB receptors. By counteracting endothelin-1, a potent vasoconstrictor that is elevated in PAH, it relaxes the lung's blood vessels, lowers pulmonary vascular resistance, and eases the load on the right side of the heart. The generic delivers the same pharmacology as the originator, which is why it can be used as a cost-saving substitute.

Indications

Bosentas is indicated for adults with pulmonary arterial hypertension (WHO Group 1), functional class II to IV. It slows disease progression and improves symptoms when taken as long-term therapy. The medicine is not a cure, and it requires regular liver and blood-count monitoring during treatment.

Dosage

The standard regimen starts at 62.5 mg twice daily for four weeks, then increases to 125 mg twice daily. The 62.5 mg and 125 mg strengths in this listing cover both phases. Take the tablets morning and evening, with or without food. Liver enzymes are checked before starting and monthly, and women of childbearing potential must use reliable contraception.

Side Effects

Common side effects include headache, flushing, fluid retention, and abnormal liver function tests. A dose-related drop in hemoglobin can occur, so blood counts are monitored. The serious risks are liver toxicity and birth defects, which is why monthly liver monitoring and strict contraception are essential during treatment.

Storage

Store Bosentas below 30°C in a dry place, in its original packaging, and away from children. No refrigeration is needed.

Why Choose the GLT?

For patients paying out of pocket, a generic such as Bosentas from India offers a major price advantage over the originator brand. The originator's Western list price is very high, while Indian generic bosentan is priced far more affordably, which can make years of daily therapy financially sustainable. GLT sources from established manufacturers and helps buyers obtain the documentation needed for safe import.

How to Order

To order Bosentas through GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. Let us know the strength, quantity, and your destination, and we will confirm availability, sourcing, and shipping terms for your region.

FAQ

Is Bosentas a generic of Tracleer? Yes. Bosentas is an Indian generic of bosentan, the active ingredient in Tracleer, produced by Cipla.

What strengths does Bosentas come in? Bosentas is available in 62.5 mg and 125 mg tablets, each in a 30-tablet pack, covering both the starting and maintenance doses.

Can I buy generic bosentan online? Many patients source generic bosentan through international suppliers like GLT. Always confirm the supplier is legitimate and provides proper documentation before ordering.

Related Oncology Products

SPINRAZA(诺西那生钠)12mg/5mL | 中国购买 | SMA 疗法 | GLT

渤健首创的反义寡核苷酸 SMA 疗法,已获 NMPA 批准并纳入中国国家医保——从 GLT 购买,价格仅为欧美的一小部分。

Barinat(巴瑞替尼)4mg | 仿制 JAK1/JAK2 抑制剂 | Natco Pharma Limited | GLT

由 Natco Pharma Limited(印度)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。

奥氟格列隆/奥格列龙(LuciOrfor)0.8–17.2mg 片剂 | 老挝仿制药 口服 GLP-1 | GLT

卢修斯制药(老挝)有限公司出品奥氟格列隆(奥格列龙)仿制药,6 档剂量递增方案,用于体重管理

KeZeRui 科瑞泽(阿伐曲泊帕)20mg*10片 | 四川科伦(中国)| GLT

KeZeRui——四川科伦药业的国采阿伐曲泊帕,中国一体化原料药+片剂制造商。

Rizonib(克唑替尼)250mg 胶囊 | 孟加拉 DIL 赛可瑞仿制药 用于 ALK+ 非小细胞肺癌 | GLT

Rizonib 250 由孟加拉通吉加济布尔的国际制药有限公司(DIL)生产——来自孟加拉的平价克唑替尼仿制药

奥氟格列隆/奥格列龙(OriYo)0.8–17.2mg 片剂 | 孟加拉仿制药 口服 GLP-1 | GLT

孟加拉国民制药(National Drug Co.)仿制奥氟格列隆,6 剂量递增用于体重管理

康曲欣 KangQuXin(阿伐曲泊帕)20mg×10片 | 北京康蒂尼(Gyre)| GLT

康曲欣 KangQuXin — 阿伐曲泊帕,北京康蒂尼药业(Gyre Therapeutics,纳斯达克:GYRE)出品,中国大陆